Tech Company Financing Transactions
Neurona Therapeutics Funding Round
Neurona Therapeutics closed a $102 million financing round on 4/3/2025. Investors included Alexandria Venture Investments, Berkeley Frontier Fund and Cormorant Asset Management.
Transaction Overview
Company Name
Announced On
4/3/2025
Transaction Type
Venture Equity
Amount
$102,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds from the financing will be used to advance the company's wholly owned pipeline of allogeneic cell therapy candidates for chronic neurological disorders.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
170 Harbor Way
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four leading-edge neuroscientists and stem cell pioneers at The University of California, San Francisco. We are focused on the discovery and development of cell-based therapies to treat intractable neurological disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Timothy Kutzkey
Chief Executive Officer
Cory Nicholas
VP - Bus. Development
Michael Greenberg
VP - Bus. Development
Catherine Priest
VP - Finance
James Tanaka
VP - Human Resources
Celinda Moore
VP - Manufacturing
Gautam Banik
VP - Operations
Alessandro Bulfone
VP - Regulatory Affairs
Estela Alvarez
VP - Regulatory Affairs
Paurene Duramad
VP - Regulatory Affairs
Sergei Shevchuk
Browse more venture capital transactions:
Prev: 4/3/2025: Mainstream Renewable Power venture capital transaction
Next: 4/3/2025: Scapia venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs